Document Classification

Section Type: RESULTS

Text: After 6 weeks of treatment, greater reductions in total cholesterol (- 35. 94 + / - 11. 38 vs. - 30. 07 + / - 10. 46 %, p < 0. 001), LDL-C (48. 04 + / - 14. 45 vs. 39. 52 + / - 14. 42 %, p < 0. 001), non-high-density lipoprotein cholesterol (- 42. 93 + / - 13. 15 vs. - 35. 52 + / - 11. 76 %, p < 0. 001), and apolipoprotein-B (- 38. 7 + / - 18. 85 vs. - 32. 57 + / - 17. 56 %, p = 0. 002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.